Koki Moriyoshi

Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing

We here report the existence of 6 additional isoforms of the NMDA receptor generated via alternative splicing by molecular analysis of cDNA clones isolated from a rat forebrain cDNA library. These isoforms possess the structures with an insertion at the extracellular amino-terminal region or deletions at two different extracellular carboxyl-terminal regions, or those formed by combinations of the above insertion and deletions. One of the deletions results in the generation of a new carboxyl-terminal sequence. All these isoforms possess the ability to induce electrophysiological responses to NMDA and respond to various antagonists selective to the NMDA receptor in the Xenopus oocyte expression system. In addition, a truncated form of the NMDA receptor also exists that contains only the extreme amino-terminal sequence of this protein molecule. These data indicate that the NMDA receptor consists of heterogeneous molecules that differ in the extracellular sequence of the amino- and carboxyl-terminal regions.

Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system.

In the developing mammalian central nervous system, neural precursor cells present in the ventricular zone determine their fate to become neurons or glial cells, migrate towards the outer layers and undergo terminal differentiation. The transcriptional repressor HES‐1, a basic helix‐loop‐helix (bHLH) factor structurally related to the Drosophila hairy gene, is expressed at high levels throughout the ventricular zone, but the level decreases as neural differentiation proceeds. Because of this negative correlation, we tested whether continuous expression of HES‐1 inhibits neural differentiation. A HES‐1 and lacZ‐transducing retrovirus (SG‐HES1) and a control lacZ‐transducing retrovirus (SG) were injected into the lateral ventricles of mouse embryos, and the fate of the infected neural precursor cells was examined by X‐gal staining. The SG virus‐infected cells migrated and differentiated into neurons and glial cells. In contrast, the cells infected with SG‐HES1 virus remained in the ventricular/subventricular zone, decreased to approximately 10% in number as compared with that of the newborn during the postnatal 4‐5 weeks and, when they survived, were present exclusively in the ependymal layer. Furthermore, whereas cultured neural precursor cells infected with SG virus became immunoreactive for neuronal and glial markers, the cells infected with SG‐HES1 virus did not. These results show that persistent expression of HES‐1 severely perturbs neuronal and glial differentiation.

Labeling Neural Cells Using Adenoviral Gene Transfer of Membrane-Targeted GFP

We describe an experimental system to visualize the soma and processes of mammalian neurons and glia in living and fixed preparations by using a recombinant adenovirus vector to transfer the jellyfish green fluorescent protein (GFP) into postmitotic neural cells both in vitro and in vivo. We have introduced several modifications of GFP that enhance its fluorescence intensity in mammalian axons and dendrites. This method should be useful for studying the dynamic processes of cell migration and the development of neuronal connections, as well as for analyzing the function of exogenous genes introduced into cells using the adenovirus vector.

Ablation of cerebellar Golgi cells disrupts synaptic integration involving GABA inhibition and NMDA receptor activation in motor coordination.

The role of inhibitory Golgi cells in cerebellar function was investigated by selectively ablating Golgi cells expressing human interleukin-2 receptor alpha subunit in transgenic mice, using the immunotoxin-mediated cell targeting technique. Golgi cell disruption caused severe acute motor disorders. These mice showed gradual recovery but retained a continuing inability to perform compound movements. Optical and electrical recordings combined with immunocytological analysis indicated that elimination of Golgi cells not only reduces GABA-mediated inhibition but also attenuates functional NMDA receptors in granule cells. These results demonstrate that synaptic integration involving both GABA inhibition and NMDA receptor activation is essential for compound motor coordination. Furthermore, this integration can adapt after Golgi cell elimination so as not to evoke overexcitation by the reduction of NMDA receptors.

Molecular characterization of NMDA and metabotropic glutamate receptors.

Our molecular studies have revealed the existence of a large number of different subunits or subtypes for the NMDA and metabotropic glutamate receptors. The individual receptors show functional variabilities and distinct expression patterns in the CNS. The NMDA receptors belong to the ligand-gated ion channel family and consist of a key subunit NMDAR1 and four accessory subunits NMDAR2A-NMDAR2D. The combination of NMDAR1 and NMDAR2 in heteromeric configurations potentiates glutamate response and produces a functional variability. All the NMDAR subunits have an asparagine residue at the corresponding position of the second transmembrane segments, and these residues are thought to be responsible for controlling Ca2+ permeation and the channel blockade by Mg2+ and cationic channel blockers. Individual NMDAR subunit mRNAs are different in their expression patterns during development and in the adult brain. The mGluR family consists of at least six different subtypes. These subtypes are divided into three subgroups according to their sequence similarities, signal transduction mechanisms, and pharmacological properties. Although their physiological roles largely remain to be elucidated, the retinal L-AP4-sensitive mGluR may have a specific function that mediates excitatory neurotransmission in the visual system. It is thus undoubtedly important to investigate specific functions of different combinations of the NMDA receptor subunits and different subtypes of mGluRs and to explore the molecular mechanisms of glutamate receptor-mediated neuronal plasticity and neurotoxicity.

Altered sensitivities to morphine and cocaine in scaffold protein tamalin knockout mice

Tamalin is a scaffold protein that interacts with metabotropic glutamate receptors and the kinase-deficient neurotrophin TrkCT1 receptor and forms a protein complex with multiple protein-trafficking and intracellular signaling molecules. In culture, tamalin promotes intracellular trafficking of group 1 metabotropic glutamate receptors through its interaction with guanine nucleotide exchange factor cytohesins and causes actin reorganization and membrane ruffling via the TrkCT1/cytohesin-2 signaling mechanism. However, how tamalin serves its physiological function in vivo has remained elusive. In this study, we generated tamalin knockout (Tam−/− KO) mice and investigated behavioral alterations resulting from their deficiency in functional tamalin. Targeted deletion of functional tamalin altered neither the overall brain architecture nor the general behavior of the mice under ordinary conditions. However, Tam−/− KO mice showed a decrease in sensitivity to acute morphine-induced hyperlocomotion and morphine analgesic effects in the hot-plate test. Furthermore, tamalin deficiency impaired the ability of the animals to show conditioned place preference after repeated morphine administration and to display locomotor sensitization by chronic cocaine treatment. Upon in vivo microdialysis analysis of the nucleus accumbens, Tam−/− KO and wild-type mice showed no genotypic differences in their response patterns of extracellular dopamine and glutamate before or after morphine administration. These results demonstrate that the tamalin scaffold protein plays a unique role in both acute and adaptive behavioral responses to morphine and cocaine and could regulate common neural substrates implicated in drugs of abuse.

Dual regulation of NR2B and NR2C expression by NMDA receptor activation in mouse cerebellar granule cell cultures

In the developing cerebellum, switching of the subunit composition of NMDA receptors occurs in granule cells from NR2B-containing receptors to NR2C-containing ones. We investigated the mechanisms underlying switching of NR2B and NR2C subunit composition in primary cultures of mouse granule cells at the physiological KCl concentration (5 mM). Granule cells extensively extended their neuritic processes 48 h after having been cultured in serum-free medium containing 5 mM KCl. Consistent with this morphological change, NR2B mRNA and NR2C mRNA were down- and up-regulated, respectively, in the granule cells. This dual regulation of the two mRNAs was abrogated by blocking excitation of granule cells with TTX. This neuronal activity–dependent regulation of NR2B and NR2C mRNAs was abolished by the addition of selective antagonists of AMPA receptors and NMDA receptors. Furthermore, the dual regulation of NR2B and NR2C mRNAs in TTX-treated cells was restored by the addition of NMDA in the presence of the AMPA receptor antagonist, but not by that of AMPA in the presence of the NMDA receptor antagonist. Importantly, the NMDA receptor activation drove the NR2B/NR2C switching of NMDA receptors in the cell-surface membrane of granule cells. This investigation demonstrates that stimulation of NMDA receptors in conjunction with the AMPA receptor–mediated excitation of granule cells plays a key role in functional subunit switching of NMDA receptors in maturing granule cells at the physiological KCl concentration.

Altered agonist sensitivity and desensitization of neuronal mGluR1 responses in knock‐in mice by a single amino acid substitution at the PKC phosphorylation site

mGluR1 and mGluR5 of the metabotropic glutamate receptor family are coupled to inositol trisphosphate–Ca2+ signal cascades and evoke distinct Ca2+ responses in neural cells and heterologously expressing cells. In heterologous cells, stimulation of recombinant mGluR1 evokes a single‐peaked Ca2+ response whereas mGluR5 elicits an oscillatory Ca2+ response. The distinct Ca2+ responses are interchangeable by single amino substitution of aspartate for threonine at the corresponding position of the carboxy‐terminal cytoplasmic regions of mGluR1 and mGluR5, respectively. In this investigation, we generated knock‐in mice, termed mGluR1 D854T mice, in which aspartate of mGluR1 was replaced with threonine. We examined the effect of this D854T substitution on Ca2+ and current responses mediated by mGluR1 in cultured cerebellar Purkinje cells. Stimulation of mGluR1 D854T by a group 1 mGluR agonist, 3,5‐dihydroxyphenylglycine (DHPG) evoked, as in wild‐type mGluR1, only single‐peaked Ca2+ responses as measured by Ca2+ fluorometric analysis. We then examined mGluR1‐induced inward currents carried by nonselective cation channels during whole‐cell recordings from cultured Purkinje cells. The mGluR1 D854T mutation abolished the responsiveness of mGluR1 to low concentrations of DHPG (0.5–500 nm) and reduced its desensitization during prolonged agonist application. mGluR1 D854T homozygous mutants showed no apparent behavioural abnormality as analysed by motor movement tests. These results indicate that, although additional modulatory mechanisms seem to be required to produce oscillatory Ca2+ responses of mGluR1, the single amino acid substitution at position 854 of mGluR1 is capable of influencing the kinetics of neuronal mGluR1 responses, most probably through PKC‐mediated phosphorylation.

SALL4 immunohistochemistry in non-small-cell lung carcinomas.

1. Sardiello M, Palmieri M, di Ronza A et al. A gene network regulating lysosomal biogenesis and function. Science 2009; 325; 473–477. 2. Settembre C, Di Malta C, Polito VA et al. TFEB links autophagy to lysosomal biogenesis. Science 2011; 332; 1429–1433. 3. Argani P, Lae M, Hutchinson B et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am. J. Surg. Pathol. 2005; 29; 230–240. 4. Kuroda N, Tanaka A, Sasaki N et al. Review of renal carcinoma with t(6;11)(p21;q12-13) with focus on clinical and pathobiological aspects. Histol. Histopathol. 2013; 28; 685–690. 5. Inamura K, Fujiwara M, Togashi Y et al. Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation. Am. J. Surg. Pathol. 2012; 36; 35–42. 6. Katzmann DJ, Odorizzi G, Emr SD. Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 2002; 3; 893–905. 7. Martignoni G, Segala D, Munari E et al. Macrophage related markers expression in MITF/TFE family renal translocation carcinoma, melanotic Xp11 translocation renal cancer and pure epithelioid PEComa (so called epithelioid angiomyolipoma) of the kidney. Mod. Pathol. 2012; 25; 226A. 8. Martignoni G, Pea M, Gobbo S et al. Cathepsin-K immunoreactivity distinguishes MITF/TFE family renal translocation carcinomas from other renal carcinomas. Mod. Pathol. 2009; 22; 1016–1022. 9. Martignoni G, Gobbo S, Camparo P et al. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod. Pathol. 2011; 24; 1313–1319.

PD-1 Regulates the Growth of Human Mastocytosis Cells

BACKGROUND Programmed death-1 (PD-1) is a marker for human neoplastic T cells. Here, we evaluated whether or not PD-1 was also a marker for human mastocytosis, and explored the role of PD-1 in human mastocytosis cells. METHODS Immunohistochemical analysis was used to evaluate the expression of PD-1 in clinical samples of human cutaneous mastocytosis. The expression of PD-1 in human mastocytosis cell lines was checked by RT-PCR, western blotting and flow cytometry. We stimulated human mastocytosis cell lines (LAD2 and HMC1.2) with recombinant ligand for PD-1, PD-L1 (rPD-L1), and tested the proliferative activity and the status of signal molecules by Cell Counting Kit-8 and ELISA, respectively. RESULTS Ten of 30 human cutaneous mastocytosis cases (33.3%) expressed PD-1 protein. We also found that a human mastocytosis line LAD2 cells expressed PD-1 protein on their surfaces. The administration with rPD-L1 suppressed the stem cell factor-dependent growth of the LAD2 cells. And, rPD-L1 activated SHP-1 and SHP-2 simultaneously, and decreased the phosphorylation of AKT, in LAD2 cells. In contrast, we could not detect the expression of PD-1, and the significant effect of rPD-L1 on the mutated KIT-driven growth of HMC1.2 cells. CONCLUSIONS PD-1 could be a marker for human cutaneous mastocytosis and regulate the growth of human PD-1-positive mastocytosis cells.